WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004009635) NOVEL POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/009635    International Application No.:    PCT/US2001/031292
Publication Date: 29.01.2004 International Filing Date: 04.10.2001
IPC:
C07K 14/47 (2006.01), C07K 14/705 (2006.01)
Applicants: CURAGEN CORPORATION [US/US]; 11th floor, 555 Long Wharf Drive, Branford, CT 06511 (US) (For All Designated States Except US).
TAUPIER, Raymond, J., Jr. [US/US]; (US) (For US Only).
MAJUMDER, Kumud [US/US]; (US) (For US Only).
SPADERNA, Steven, K. [US/US]; (US) (For US Only).
SMITHSON, Glennda [US/US]; (US) (For US Only).
MEZES, Peter, S. [CA/US]; (US) (For US Only).
VERNET, Corine, A., M. [FR/US]; (US) (For US Only)
Inventors: TAUPIER, Raymond, J., Jr.; (US).
MAJUMDER, Kumud; (US).
SPADERNA, Steven, K.; (US).
SMITHSON, Glennda; (US).
MEZES, Peter, S.; (US).
VERNET, Corine, A., M.; (US)
Agent: ELRIFI, Ivor, R.; Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C., One Financial Center, Boston, MA 02111 (US)
Priority Data:
09/813,432 20.03.2001 US
Title (EN) NOVEL POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME
(FR) NOUVEAUX POLYPEPTIDES ET ACIDES NUCLEIQUES LES CODANT
Abstract: front page image
(EN)The present invention provides novel isolated NOVX polynucleotides and polypeptides encoded by the NOVX polynucleotides. Also provided are the antibodies that immunospecifically bind to a NOVX polypeptide or any derivative, variant, mutant or fragment of the NOVX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the NOVX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
(FR)L'invention concerne des nouveaux polynucléotides isolés NOVX et des polypeptides codés par lesdits polynucléotides NOVX. L'invention concerne également les anticorps qui lient de manière immunospécifique des polypeptides NOVX ou que tout dérivé, variant, mutant ou fragment du polypeptide, polynucléotide ou anticorps NOVX. L'invention concerne de plus des procédés dans lesquels les polypeptides, polynucléotides ou anticorps NOVX sont utilisés pour la détection et le traitement d'une grande gamme d'états pathologiques, ainsi que d'autres utilisations.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)